A paradigm shift in developments of anti-Candida drugs.
The considerable augment in the incidence of candida infection in the recent times have prompted the use of numerous anti fungal agents which has resulted in the development of resistance towards various anti fungal agents. With rising candida infections, the need for the novel anti fungal agents has been in demand. However, the new therapeutic approaches are very much essential in preventing the mortality rate and improving the patient outcome suffering from candida infections. Hence the present review describes burden, classes of candidiasis and the mechanism of anti fungal agents. The review briefs on the natural plant extract and essential oils as a source of newer therapeutic agents and focuses novel strategies such as combinational therapy with emphasises on development of effective vaccination, new antibodies, utilization of photodynamic therapy and adaptive transfer primed immune cells.